Monday 24th July 2006 Detailed Programme
Plenary 1: Controversies and Consensus in Cardiovascular Disease
Chairs: David Colquhoun & Kerin O’Dea
Plenary 1.1 N-3 fatty acids, mortality and coronary heart disease: evidence from randomised controlled trials.
Rudolph Riemersma, Scotland
Plenary 1.2 Antioxidants – do they do anything?
Kevin Croft, Australia
Plenary 1.3 What are the health effects of trans fat and cla? All bad for industrially produced trans fat, and both good and bad for cla.
Penny Kris-Etherton, USA
Chairs: Manohar Garg & Wendy Oddy
CS 1.1 Does EPA decrease recurrence rates in radically operated prostate cancer patients? A randomized controlled trial.
Hamazaki T.
CS 1.2 Dietary polyunsaturated fatty acids and progression of prostatic cancer to androgen-independent growth.
Whelan J.
CS 1.3 Arachidonic acid and cox-2 activities as selective prognostic markers for phase treatments during laryngeal oncogenesis.
Louw L.
CS 1.4 The omega-3 fatty acid DHA induces er-stress in human colon cancer cell lines and the unfolded protein response is a prominent feature of the growth-inhibitory effect.
Bremseth H.
CS 1.5 Inhibitory effect of isomers of CLA on the growth of human cancer cell lines.
Larsen A.
CS 1.6 Docosahexaenoic acid induces cell cycle arrest in the human colon cancer cell lines sw480 and sw620. Jakobsen C.
Chairs: Marius Smuts & Beth Levant
CS 2.1 Detection of 16 and 18 carbon trans monoene fatty acids in cerebellar cortex of normal aged elderly humans.
Brenna T.
CS 2.2 High-normal levels of dietary docosahexaenoate increase dha in cerebral cortex but not basal ganglia/limbic in 12 week old baboon neonates.
Hsieh A.
CS 2.3 Decreased p38 mapk activity, creb dna binding activity, and bdnf expression in the frontal cortex of n-3 pufa deprived rats.
Bazinet R.
CS 2.4 One generation model of n-3 fatty acid deficiency in rodents using artificial rearing: brain composition and behavior.
Moriguchi T.
CS 2.5 Hippocampal docosahexaenoic acid level is associated with learning memory performance.
Su H-M.
Chairs:Michel de Lorgeril & Sean Strain
CS 3.1 Rationale, study design, and outcome measures from recently completed uk-based trials investigating long chain n-3 fatty acids and cardiovascular risk factors (FINGEN) and atherosclerotic plaque inflammation (OCEAN).
Calder P.
CS 3.2 The anti-inflammatory action of modest dose fish oil intakes in healthy adults (the FINGEN study).
Kofler B.
CS 3.3 Plasma lipid response to modest dose fish oil intake: impact of genotype, gender and age (the FINGEN study).
Minihane A.
CS 3.4 A multi-centre randomised clinical trial: study on omega-3 fatty acids and ventricular arrhythmia (SOFA).
Brouwer I.
CS 3.5 The effect of dietary n-3 polyunsaturated fatty acids on inducible ventricular arrhythmias in humans.
Metcalf R.
CS 3.6 Relationship between platelet phospholipid fatty acid and thrombotic risk factors in middle aged and geriatric hyperlipaemia patients.
Li D.
Chairs: Jing Kang & Linda Schaeffer
CS 4.1 Increased supply of lc-pufa through plant biotechnology.
Green A.
CS 4.2 Occurrence novel cyclic sulfur-containing fatty acids in garlic (allium sativum).
Dembitsky V.
CS 4.3 Use of enzymes in the production of omega-3 based active pharmaceutical ingredients and nutraceuticals.
Kralovec J.
CS 4.4 The antioxidant, anti-inflammatory and hypolipidemic properties of a seleno-substituted fatty acid.
Rost T.
CS 4.5 Bioconversion of n-6 and n-3 pufas by bacillus megaterium ALA2.
Hou C.
Chairs: Bruce Holub & Roxanne Portolesi
CS 5.1 Comparison of algal docosahexaenoic acid (DHA) oils and fortified foods on plasma fatty acid levels.
Arterburn L.
CS 5.2 Sex differences in serum n-3 long-chain polyunsaturated fatty acids: results from a population-based survey of New Zealanders.
Crowe F.
CS 5.3 Advice that identifies core foods rich in polyunsaturated fat is effective for achieving optimal fat intake.
Quick C.
CS 5.4 Trans octadecenoic and trans octadecadienoic, but not trans hexadecenoic acids are inversely related to long-chain polyunsaturated fatty acids in human milk.
Decsi T.
CS 5.5 Determining human equivalent doses of n-3 pufa in rodent diets for improved pre-clinical screening using animal models.
Whelan jJ.
CS 5.6 Consumption of an n-3 polyunsaturated fatty acid enriched dip modulate plasma lipid profile in people with diabetes type II.
Garg M.
Chairs: Richard Bazinet & Hui-min S.
CS 6.1 Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the rat.
Michael-Titus A.
CS 6.2 Effect of phosphatidylserine-docosahexaenoic acid (PS-DHA) on the learning ability of n-3 fatty acid deficient mice.
Moriguchi T.
CS 6.3 ALA is inadequate to allow short-term recovery of brain DHA following omega 3 pufa deficiency.
Sinclair A.
CS 6.4 Differential transcriptomes of liver and cerebral cortex of baboon neonates consuming medium and high DHA.
Kothapalli K.
CS 6.5 Maternal parity influences the effects of an α-linolenic-deficient diet on maternal and offspring brain docosahexaenoic acid content.
Levant B.
Concurrent Session 7 Dietary PUFA & cholesterol (sponsored by Columbus Paradigm Institute)
Chairs: Bill Lands & Karen Murphy
CS 7.1 Re-evaluation of the 7-Country Study indicates long chain omega-6 hufas as a primary risk factor.
De Meester F.
CS 7.2 Cholesterol lowering and mortality.
De Lorgeril M.
CS 7.3 High blood cholesterol as predictor for low cancer mortality and longevity.
Okuyama H.
CS 7.4 Is it necessary to lower blood cholesterol levels below 240mg/dl (6.2mmol/l) in Japan even if there are no other risks?
Hamazaki T.
CS 7.5 The myths of cholesterol and saturated fat .
Ravnskov U.
CS 7.6 The challenges in marketing functional foods.
Challands P.
Concurrent Session 8 Lipids in parenteral & enteral nutrition
(sponsored by Baxter and AUSPEN)
Chairs: Maria Makrides & Sybille Koletzko
CS 8.1 Lipids currently used in australasian nutritional support.
Marshall K.
CS 8.2 Parenteral lipid supply for infants and children.
Koletzko B.
CS 8.3 Lipids in adult intensive care.
Davies A.
Chairs: Maria Makrides & Michael James
Plenary 2.1 Docosahexaenoic acid signaling in Ageing, Stroke and Alzheimers Disease.
Nicolas Bazan, USA.
Selected short communications
Plenary 2.2 Dietary omega-3 fatty acids decrease intraocular pressure with age.
Nguyen C.
Plenary 2.3 Dietary omega-3 long-chain polyunsaturated fatty acid intake is associated with visual acuity performance in the age-related eye disease study (AREDS).
San Giovanni J.
Plenary 2.4 Genomic studies on the brain of transgenic mouse capable of converting n-6 to n-3 fatty acids.
Puskas L.
Poster Session A
P001 Protective effects of burdock (arctium lappa linne) on oxidation of low-density lipoprotein and nitric oxide production . Duh P
P002 Consuming a fortified beverage for 7 months does not lead to increase in overall energy intake in children 5-7 years of age. Lien V.
P003 Enhanced contribution of both n-3 and n-6 long-chain polyunsaturated fatty acids to plasma lipids in patients with inflammatory bowel disease. Decsi T.
P004 Increasing the eicosapentaenoic acid and docosahexaenoic acid content of a test meal does not alter postprandial lipaemia in men and post-menopausal women aged 50 to 65 years. Calder P.
P005 Withdrawn.
P006 Fetal rat plasma dha status is enhanced by a maternal diet rich in linseed or salmon oil, and compromised by a maternal diet rich in sunflower oil . Childs C.
P007 Sunflower oil feeding enhances the reduction in maternal lymphoid organ cellularity observed during pregnancy in rats .Childs C.
P008 Lack of effect of gender on postprandial changes in triglyceride n-3 polyunsaturated fatty acid concentrations in middle-aged subjects. Sala-Vila A.
P009 Long chain pufa in a population of elderly, acutely sick patients admitted to a general medical ward. Lindberg M.
P010 Health risks and benefits of trans fatty acids in food –French recommendations. Leger C-L.
P011 Spontaneous and diet-induced low level of n-3 polyunsaturated fatty acids (pufa) in the frontal cortex is associated with different kinds of hyperactivity in the rat. Guestnet P.
P012 Dietary n-3 polyunsaturated fatty acids and tissue changes: a systematic review of the human literature. Whelan J.
P013 Detection and identification of phospholipids in normal human tears using tandem mass spectrometry . Zhao Z.
P014 Arachidonic and docosahexaenoic acid composition of thoracic aorta of adult rats. RenH.
P015 Trout farm waste material as a potential source of omega-3 polyunsaturated fatty acids: study of lipid and fatty acid tissue distribution. Guschina I.
P016 The effectiveness of dpa rich seal oil compared with fish oil in lowering plasma triglycerides and increasing hdl-cholesterol in hypertriglyceridaemic subjects. Meyer B.
P017 Fatty acid and sn2 fatty acid composition of goat milk. Prosser C.
P018 Dietary canola oil intake elevates plasma lipid levels and depresses antioxidative enzyme activities in spontaneously hypertensive rats (SHR). Ohara N.
P019 Withdrawn
P020 Lower docosahexaenoic acids in plasma choline phospho-glycerides of smoking pregnant women. Wang Y.
P021 Omega 3 and 6 fatty acid compostion of colostrums from three regions of China: AA and DHA in colostrums and maternal plasma choline phosphoglycerides are positivley associated. Wang Y.
P022 Omega-3 fatty acids modulate antioxidant status and t cell activation in diabetic pregnancy and obesity. Yessoufou A.
P023 Whole body fatty acid balance analysis in EFA deficient versus specifically w-6 fatty acid deficient rats. Cunnane S.
P024 Anti-atherogenic effects of a daily intake of salmon paté rich in long chain omega-3 fatty acids compared to fish oil capsules. Lamglait A.
P025 Doses of long chain omega-3 polyunsaturated fatty acids required for health benefits – summary of the literature . Sparkes C.
P026 Effect of estradiol on the incorporation of newly synthesized docosahexaenoic acid into phospholipids of SH-SY5Y neuroblastoma cells. Guesnet P.
P027 Impact of omega-6 and omega-3 fatty acid supplementation on membrane fa composition and glucose transport activity in two in vitro models of the blood-brain barrier, the rat brain endothelial cell primary culture and the cell line RBE4 . Guesnet P.
P028 Estimations of healthy intakes of n-3 and n-6 fatty acids considering worldwide diversity of apparent consumption and disease risk. Hibbeln J.
P029 Docosahexaenoic acid enrichment of very low density lipoproteins (vldl) and hepatocyte ldl uptake: impact of apo-E genotype .Minihane A.
P030 Plasma and RBC fatty acids in transplant patients treated with canola oil or Coromega®. Alexander J
P031 DHASCO-t and DHASCO-s are bioequivalent dietary sources of DHA for DHA accretion in growing piglets. Brenna T.
P032 Effects of erabu sea snake lipids on endurance capacity of mice. Higuchi T.
P033 Fatty acid intakes of pregnant women with pre-gestational type 1 diabetes. Ren H.
P034 Early dietary treatments with Lorenzo’s Oil and docosahexaenoic acid are efficient for neurological findings in a case with Zellweger Syndrome. Tanaka K.
P035 A comparative study investigating attitudes, beliefs and intentions towards the consumption of foods with omega-3 polyunsaturated fatty acids: does information mediate between attitudes, intentions and behaviour?. Summers J.
P036 Future sources of dietary oil for atlantic salmon salmo salar l. Miller M.
P037 Delta-6 desaturase knockout mouse indicates presence of isozyme in liver. Stroud C.
P038 Review of the systematic reviews of omega 3 fatty acids and coronary heart disease and mortality. Colquhoun D.
P039 Dose-dependent effects of dha-rich tuna oil on cardiovascular and inflammatory biomarkers. Coates A.
P040 The fatty acid content of forty-four kinds of fish available in Dalian-city and Hangzhou-city, China. Hamazaki T.
P041 What kind of factors are associated with the RBC omega-3 index in Japanese?. Hamazaki T.
P042 Erythrocyte membrane docosahexaenoic and arachidonic acid status in pregnant south indian women: relation with essential fatty acid intake. Muthayya S.
P043 Essential fatty acid consumption in pregnant South Indian women: relation with birth outcome . DwarkanathP.
P044 Dietary n-3 polyunsaturated fatty acids decrease spontaneous beating rate in the rat heart. Henry R.
P045 Combining effects of dietary pufa and polyphenols on anti-atherosclerosis in human endothelial ecv 304 cells. Lee M.
P046 Impact of food composition databases on fatty acid research. Wolmarans P.
P047 Correlation of erythrocye n-6 to n-3 fatty acid ratio with disease severity in multiple sclerosis. Smuts C.
P048 Oral treatment of essential fatty acid deficiency with triglycerides or phospholipids in chronic pediatric cholestasis . Werner A.
P049 Analysis of lipids of Pacific oyster crassostrea gigas between the Pacific and Atlantic oceans. Saito H.
P050 Analysis of lipids of turban shell batillus cornutus. Saito H.
P051 Female washout response to omega-3 fatty acid supplementation in plasma, erythrocytes and whole blood. Thienprasert A.
P052 Dietary intakes of docosahexaenoic acid (dha) and eicosapentanoic acid (epa) in 1-12 year old us children. Zhou D.
P053 Venous thrombosis risk in rats submitted to diets containing differents lipid sources. Mizurini D.
P054 Effect of fish oil supplementation on arterial stiffness and markers of inflammation in healthy individuals. Thies F.
P055 Patterns of fish consumption and levels of erythrocyte docosahexaenoic acid in a population study of adolescents Oddy W.
P056 New crop plant and single cell sources of long-chain omega-3 oils. Nichols P.
P057 New Australian thraustochytrids: an alternate source of omega-3 long-chain polyunsaturated fatty acids. Nichols P.
P058 The effect of feeding dietary EPA and DHA on immune cell characteristics and cytokine production in the obese and insulin resistant JCR:LA-CP rat. Ruth M.
P059 Co-supplementation with evening primrose oil and fish oil does not lower arachidonic acid status and increases dihomo-gamma-linolenic acid status in women of childbearing age.Koletzko B.
P060 Pharmacological delta-6 desaturase inhibition and associated lipid disorders in spontaneously hypertensive rat. Narce M.
P061 Oxidative stress response in thai school age children supplemented with omega-3 fatty acids . Thienprasert A.
P062 Antithetic eco-physiological relationship between dietary DHA;EPA and ARA: possible evolutionary repercussions. Zhou D.
P063 Withdrawn
P064 Characterisation of the milk fat globule membrane proteins from goats’ milk. Hodgkinson A.
|
Archive